Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600122118) titled 'Role and Mechanism of CPT1C in Mediating Cancer-Associated Fibroblast Senescence via Lipid Metabolic Reprogramming to Promote Gastric Cancer Malignant Progression and Immune Evasion' on April 9.

Study Type: Observational study

Study Design: Sequential

Primary Sponsor: Ningbo Medical Centre Lihuili Hospital

Condition: Gastric cancer

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-09

Target Sample Size: Gastric Malignant Tumor Observation Group:50;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=306673

Published by HT ...